BioSpace News Archive

We at the Association for Diagnostics & Laboratory Medicine provided testimony to Congress regarding the impact of the Food and Drug Administration’s proposed rule to impose FDA oversight on laboratory developed tests in addition to Centers for Medicare & Medicaid Services oversight.

Kazia Therapeutics Limited (NASDAQ: KZIA) is pleased to announce that it has entered into an exclusive licensing agreement with Sovargen Co., Ltd, a biotechnology company specializing in central nervous system (CNS) diseases, to develop, manufacture and commercialise paxalisib as a potential treatment of intractable epilepsy in focal cortical dysplasia type 2 (FCD T2) and tuberous sclerosis complex (TSC) disease.

SciSparc Ltd. announced that MitoCareX Bio Ltd. (“MitoCareX”) had virtually screened millions of small molecules by using its computationally advanced drug discovery platform, which resulted in the identification of several molecules that could be used for potential anti-cancer treatments.

Centinel Spine®, LLC (“the Company”) today announced that it will sponsor an upcoming major worldwide live webinar symposium on the current state of TDR options for patients with chronic cervical disc disease.

Blue Lake Biotechnology, Inc. today announced preliminary data from the first two cohorts of a Phase 1/2a clinical trial studying BLB201, the company’s investigational vaccine against severe respiratory syncytial virus (RSV) disease.

LivaNova PLC, a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time.

Gemina Laboratories Ltd. is pleased to provide a strategic update and outlook for 2024 and beyond.

HemoSonics, a medical device company focused on acute bleeding management, announced it has been named to the prestigious list of Fast Company’s Most Innovative Companies for 2024.

Co-Diagnostics, Inc. announced that in his keynote address at the 5th Annual MarketsandMarkets conference in London, Company CEO Dwight Egan shared an update on the new manufacturing facilities in Salt Lake City, Utah and in Ranoli, India, including announcing the grand opening of the new Utah facility next month.

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) today announced that investigators at the Louis Stokes Cleveland Veterans Affairs Medical Center, led by Katarina B. Greer, M.D.,M.S., Associate Professor of Medicine at Case Western Reserve University School of Medicine, have released data from a Department of Defense funded prospective clinical validation study of patients who met strict national society guideline criteria for esophageal precancer testing.